Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis

This is the first study which includes a biosimilar drug in the meta-analysis of biological treatments in AS. The results have proven the similar efficacy and safety profile of infliximab-biosimilar treatment compared to other biologicals. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014

MoreLess

Year of publication:	2014
Authors:	Baji, Petra ; Péntek, Márta ; Szántó, Sándor ; Géher, Pál ; Gulácsi, László ; Balogh, Orsolya ; Brodszky, Valentin
Published in:	The European Journal of Health Economics. - Springer. - Vol. 15.2014, 1, p. 45-52
Publisher:	Springer
Subject:	Ankylosing spondylitis \| Biological drug \| Biosimilar pharmaceuticals \| Meta-analysis \| Efficacy \| Safety

Online Resource

Check full text access |

More access options

Check Google Scholar

In German libraries (KVK)

I need help

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10010993915